Spain - Sold Production of Medicaments of Alkaloids or Derivatives Thereof Not Packaged for Retail Sale
Since 2014, Spain Sold Production of Medicaments of Alkaloids or Derivatives Thereof Not Packaged for Retail Sale was up 0.6% year on year. With €7,501,293 in 2019, the country was number 2 among other countries in Sold Production of Medicaments of Alkaloids or Derivatives Thereof Not Packaged for Retail Sale. Italy topped the ranking with €23,190,691.46 in 2019, that is +3.4% versus 2018. Poland witnessed the best average annual growth at +37.3% per year, while Spain recorded the worst performance at +0.6% per year.
Loading...
| Date | Euros |
|---|---|
| 2019 | 7,501,293.00 |
| 2018 | 7,578,828.00 |
| 2017 | 6,314,366.00 |
| 2016 | 7,048,178.00 |
| 2015 | 5,633,498.00 |
Download all data from 2005 to 2019
How does Spain rank in Sold Production of Medicaments of Alkaloids or Derivatives Thereof Not Packaged for Retail Sale?
| # | 3 Countries | Euros | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
Italy
|
23,190,691.46 | 2019 | +3.4 % | +3.6 % | View data |
| 2 |
#2
Spain
|
7,501,293.00 | 2019 | -1.0 % | +0.6 % | View data |
| 3 |
#3
Poland
|
6,994,016.42 | 2019 | +55.1 % | +37.3 % | View data |